Merck KGaA
F:MRKC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Merck KGaA
F:MRKC
|
DE |
|
S
|
Sabra Health Care REIT Inc
SWB:SBC
|
US |
|
C
|
Chubb Ltd
SWB:AEX
|
CH |
|
A
|
Agnico Eagle Mines Ltd
LSE:0R2J
|
CA |
|
Stora Enso Oyj
LSE:0CXC
|
FI |
|
A
|
Ajinomoto Co Inc
XMUN:AJI
|
JP |
|
M
|
Mercadolibre Inc
LSE:0K0E
|
AR |
|
F
|
Fifth Third Bancorp
SWB:FFH
|
US |
Wall St Price Targets
MRKC Price Targets Summary
Merck KGaA
According to Wall Street analysts, the average 1-year price target for MRKC is 27.3 EUR with a low forecast of 21.4 EUR and a high forecast of 35.75 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MRKC's stock price target?
Price Target
27.3
EUR
According to Wall Street analysts, the average 1-year price target for MRKC is 27.3 EUR with a low forecast of 21.4 EUR and a high forecast of 35.75 EUR.
What is the Revenue forecast for Merck KGaA?
Projected CAGR
3%
Over the last 14 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 3%.
What is the Operating Income forecast for Merck KGaA?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 5%.
What is the Net Income forecast for Merck KGaA?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 8 years is 10%.
